BioCentury
ARTICLE | Clinical News

Octamer Inc. regulatory update

December 6, 1993 8:00 AM UTC

Octamer received U.S. Patent No. 5,262,564 covering sulfinic acid adducts of nitroso compounds. The compounds eject zinc from zinc fingers, inactivating retroviruses and killing tumor cells. Octamer s...